Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia

被引:31
作者
O'Brien, SG [1 ]
Deininger, MWN
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Sch Clin & Lab Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Oregon Hlth Sci Univ, Inst Canc, BMT Leukemia Ctr, Portland, OR 97201 USA
关键词
D O I
10.1053/shem.2003.50058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:26 / 30
页数:5
相关论文
共 15 条
  • [1] A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
    Baccarani, M
    Rosti, G
    de Vivo, A
    Bonifazi, F
    Russo, D
    Martinelli, G
    Testoni, N
    Amabile, M
    Fiacchini, M
    Montefusco, E
    Saglio, G
    Tura, S
    [J]. BLOOD, 2002, 99 (05) : 1527 - 1535
  • [2] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
    Druker, BJ
    Sawyers, CL
    Kantarjian, H
    Resta, DJ
    Reese, SF
    Ford, JM
    Capdeville, R
    Talpaz, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042
  • [3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Druker, BJ
    Talpaz, M
    Resta, DJ
    Peng, B
    Buchdunger, E
    Ford, JM
    Lydon, NB
    Kantarjian, H
    Capdeville, R
    Ohno-Jones, S
    Sawyers, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037
  • [4] Transplantation in chronic myeloid leukaemia
    Gratwohl, A
    Baldomero, H
    Urbano-Ispizua, A
    [J]. LANCET, 2002, 359 (9307) : 712 - 713
  • [5] Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
    Guilhot, F
    Chastang, C
    Michallet, M
    Guerci, A
    Harousseau, JL
    Maloisel, F
    Bouabdallah, R
    Guyotat, D
    Cheron, N
    Nicolini, F
    Abgrall, JF
    Tanzer, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) : 223 - 229
  • [6] HAHN EA, IN PRESS J CLIN ONCO
  • [7] A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa
    Hasford, J
    Pfirrmann, M
    Hehlmann, R
    Allan, NC
    Baccarani, M
    Kluin-Nelemans, JC
    Alimena, G
    Steegmann, JL
    Ansari, H
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11): : 850 - 858
  • [8] HUGHES TP, UNPUB FREQUENCY MAJO
  • [9] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
    Kantarjian, H
    Sawyers, C
    Hochhaus, A
    Guilhot, F
    Schiffer, C
    Gambacorti-Passerini, C
    Niederwieser, D
    Resta, D
    Capdeville, R
    Zoellner, U
    Talpaz, M
    Druker, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) : 645 - 652
  • [10] KAPLAN E, 1958, J AM STAT ASSOC, V4, P445